Reviewing the clinical aspects of HIV-associated pulmonary hypertension

Journal of Respiratory Diseases

Volumn 25, Issue 7, 2004, Pages 289-293

  Barbaro, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; CALCIUM CHANNEL BLOCKING AGENT; PROSTACYCLIN; SILDENAFIL;

ARTERIAL GAS; CLINICAL FEATURE; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; HEART ATRIUM ENLARGEMENT; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LUNG FUNCTION; LUNG SCINTISCANNING; LUNG VENTILATION PERFUSION RATIO; NONHUMAN; PATHOGENESIS; PULMONARY HYPERTENSION; REVIEW; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THORAX RADIOGRAPHY; TRICUSPID VALVE REGURGITATION;

EID: 3142680824     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Kim KK, Factor SM. Membrano-proliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome. Hum Pathol. 1987;18:1293-1296.
2. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA. HIV-related pulmonary hypertension: analytic review of 131 cases. Chest. 2000;118:1133-1141.
3. Rich S, ed. Primary pulmonary hypertension: executive summary. World Symposium-Primary Pulmonary Hypertension 1998. Evian, France; September 6-10, 1998.
4. Mette SA, Palevsky HI, Pietra GG, et al. Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis. 1992;145:1196-1200.
5. Humbert M, Monti G, Fartouk M, et al. Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J. 1998;11:554-559.
6. Giaid A, Yanagisawa M, Langreben D. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732-1739.
7. Giaid A. Nitric oxide and endothelin-1 in pulmonary hypertension. Chest. 1998;114:208S-212S.
8. Cacoub P, Dorent R, Nataf P, et al. Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res. 1997;33:196-200.
9. Pellicelli AM, Palmieri F, D'Ambrosio C, et al. Role of human immunodeficiency virus in primary pulmonary hypertension-case reports. Angiology. 1998;49:1005-1011.
10. Salvi SS. Alpha1-adrenergic hypothesis for pulmonary hypertension. Chest. 1999;115: 1708-1719.
11. Tomashefski JF, Hirsch CS. The pulmonary vascular lesions of intravenous drug abuse. Hum Pathol. 1980;11:133-145.
12. Pellicelli AM, Barbaro G, Palmieri F, et al. Primary pulmonary hypertension in HIV patients: a systematic review. Angiology. 2001;52:31-41.
13. Branch CA, Knuepfer MM. Adrenergic mechanisms underlying cardiac and vascular responses to cocaine in conscious rats. J Pharmacol Exp Ther. 1992;263:742-751.
14. Hadengue A, Benhayoun MK, Lebrec D, et al. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology. 1991;100:520-528.
15. Kuddus RH, Nalesnik MA, Subbotin VM, et al. Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes-an important mechanism of increased endogenous levels of ET-1 in liver cirrhosis. J Hepatol. 2000; 33:725-732.
16. Morse JH, Barst RJ, Itescu S, et al. Primary pulmonary hypertension in HIV infection: an outcome determined by particular HLA class II alleles. Am J Respir Crit Care Med. 1996;153: 1299-1301.
17. Itescu S, Dalton J, Zhang HZ, Winchester R. Tissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the phenotypic appearance of an antigenically driven response. J Clin Invest. 1993;91:2216-2225.
18. Itescu S, Brancato LJ, Winchester W. A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet. 1989;2: 466-468.
19. Barbaro G, Fisher SD, Upshultz SE. Pathogenesis of HIV-associated cardiovascular complications. Lancet Infect Dis. 2001;1:115-124.
20. Opravil M, Pechère M, Speich R, et al. HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med. 1997;155:990-995.
21. Petitpretz P, Brenot F, Azarian R, et al. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation. 1994;89:2722-2727.
22. Aguilar RV, Farber HW. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension. Am J Respir Crit Care Med. 2000; 162:1846-1850.